Nymox Pharmaceutical
NYMX
#9940
Rank
HK$0.14 B
Marketcap
Country
HK$1.56
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -HK$17.02 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -HK$50.76 Million, an increase over its 2021 earnings that were of -HK$97.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -HK$17.02 Million-66.47%
2022 -HK$50.76 Million-47.71%
2021 -HK$97.08 Million6.61%
2020 -HK$91.06 Million-10.91%
2019 -HK$0.11 Billion24.24%
2018 -HK$82.26 Million-20.03%
2017 -HK$0.11 Billion2.71%
2016 -HK$0.11 Billion-63.86%
2015 -HK$0.28 Billion674.44%
2014 -HK$35.79 Million-6.11%
2013 -HK$38.12 Million-35.66%
2012 -HK$59.25 Million-20.76%
2011 -HK$74.77 Million38.33%
2010 -HK$54.05 Million35.59%
2009 -HK$39.87 Million11.8%
2008 -HK$35.66 Million-12.94%
2007 -HK$40.96 Million8.85%
2006 -HK$37.63 Million36.5%
2005 -HK$27.57 Million-4.4%
2004 -HK$28.84 Million-14.58%
2003 -HK$33.76 Million
2001 -HK$24.77 Million-20.54%
2000 -HK$31.17 Million21.72%
1999 -HK$25.61 Million-25.56%
1998 -HK$34.4 Million101.3%
1997 -HK$17.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$52.71 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$53.99 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$8.65 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$78.94 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$135.65 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA